A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Introduction. Gemcitabine and cisplatin (GC) is a gold-standard first-line systemic chemotherapy for advanced urothelial carcinoma (UC). However, it may cause severe adverse effects such as renal toxicity, gastrointestinal toxicity, and neurotoxicity. Sarcopenia is the age-related loss of skeletal m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasahara, Ryo, Kawahara, Takashi, Ohtake, Shinji, Saitoh, Yoko, Tsutsumi, Sohgo, Teranishi, Jun-ichi, Miyoshi, Yasuhide, Nakaigawa, Noboru, Yao, Masahiro, Kobayashi, Kazuki, Uemura, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406717/
https://www.ncbi.nlm.nih.gov/pubmed/28497065
http://dx.doi.org/10.1155/2017/7981549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406717/
https://www.ncbi.nlm.nih.gov/pubmed/28497065
http://dx.doi.org/10.1155/2017/7981549

Ejemplares similares